Cancer Advances
Subscribe:
Featured Episode
Trailblazing Urothelial Cancer Treatments: Enfortumab Vedotin & Pembrolizumab
Shilpa Gupta, MD, Director of the Genitourinary Oncology Program at Cleveland Clinic Cancer Institute, provides an overview of the clinical trial of enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. Listen as Dr. Gupta talks about the exciting results of the trial, which showed that the combination therapy was effective for both cisplatin-eligible and cisplatin-ineligible patients. She also highlights the future studies that are being conducted to explore the use of the therapy in the neoadjuvant setting.
Play NowAll Cancer Advances Episodes
April 18, 2024
Beyond Chemotherapy: Advancements in ALL Treatment
Anjali Advani, MD, Director of the Inpatient Leukemia Unit at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the innovations in acute lymphoblastic leukemia (ALL). While chemotherapy has traditionally been the go-to treatment, advancements like blinatumomab and CAR-T cell therapy are reshaping care. Listen as Dr. Advani discusses the challenges and considerations in choosing these therapies, CAR-T re-challenge potential, and the future directions in ALL treatments.
Play NowApril 11, 2024
In the Pursuit of Parenthood: Pregnancy, Breast Cancer, and BRCA Mutations
Halle Moore, MD, Director of Breast Medical Oncology at Cleveland Clinic, joins the Cancer Advances Podcast to explore the safety of pregnancy after breast cancer with BRCA mutations. In the episode, Dr. Moore emphasizes the importance of early conversations regarding reproductive goals and available fertility preservation strategies for breast cancer patients while maintaining an effective cancer treatment. Despite limited data on this topic, Dr. Moore highlights positive outcomes observed in retrospective studies.
Play NowApril 4, 2024
Exploring Novel Strategies for Chronic Lymphocytic Leukemia
Hematology oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss the latest innovations in treating chronic lymphocytic leukemia (CLL). Listen as she explains how the treatment for CLL has evolved over the past decade, with a shift towards using novel therapies such as BTK inhibitors and venetoclax, as well as the concept of time-limited therapy. Dr. Winter also shares insights into ongoing clinical trials like the MAJIC trial, which compares different treatment combinations.
Play NowMarch 28, 2024
Enhancing Patient Care with Cancer Programming
Alison Ibsen, Senior Director for Cancer Programming, joins the Cancer Advances Podcast to talk about the role of cancer programming to enhance cancer patient care. Cancer programming brings together various experts involved in the treatment of a specific cancer to promote multidisciplinary care to help improve outcomes. Listen as Alison elaborates on the program development, its emphasis on creating effective care pathways, and the importance of collaboration across different locations and departments within Cleveland Clinic.
Play Now
